Vivimed Labs share news, announcements and annual reports
NSE: VIVIMEDLABBSE: 532660Pharmaceuticals & BiotechnologySmall Cap
Vivimed Labs Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2005
Last close ₹5.64down ₹0.11 (1.91%)
Share price at the NSE close on 29 Oct 2026. Previous close ₹5.75.
29 Oct: open ₹5.65, high ₹5.65, low ₹5.64
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹47 Cr3,293rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,884
Vivimed Labs share news and announcements
642 announcements, routine notices left out, newest first. Page 13 of 13.
Sep 2009
8 Sep · Corporate action
Company shall close its books for Declaration of Dividend and for Annual General Meeting from September 28, 2009 to September 30, 2009 (both days inclusive). The dividend if declared in the Annual General Meeting of the Company by its members, shall be payable on or after the October 05, 2009.2 Sep · Buy-back/others
Vivimed Labs Limited, manufacturers of specialty Chemicals, has successfully completed buyback of its foreign currency convertible bonds (FCCBs) of USD 15.0 mn issued in April 2007, maturing for redemption in April 2012. The bonds are convertible into equity shares at a price determined as per terms of Offer subject to floor price of Rs 185 per share. Of the total issue, bonds worth USD 12.5 mn were bought back and Bondholders opted for conversion of balance Bonds worth USD 2.5 mn into equity shares. The Company in its Board Meeting held on 31st August, 09 considered allotment of equity shares to the Bondholder and has issued 5,63,918 equity shares of the Company, converted at Rs. 185 per equity share
Aug 2009
14 Aug · Management
Mr. Y Krishna has been appointed as an Additional Director on the Board of Vivimed Labs Limited with effect from June 30, 2009 in the Board Meeting of the Company held on June 30, 2009.
Jul 2009
23 Jul · Board meeting
Meeting on 31 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”3 Jul · Updates
Financial results of the Company for the year ended March 31, 2009 pursuant to Clause 20 (b) of the Listing Agreement. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Jul · Dividend
Board of Directors of the Company at its meeting held on June 30, 2009 the Board has recommends a dividend of Rs. 1.50 per equity shares (15%) amounting to Rs. 141 Lakhs plus tax on dividend of Rs. 23.96 Lakhs.
Jun 2009
23 Jun · Board meeting
Inter-alia to consider and take on record and approve the Audited Financial Results for the year ended March 31, 2009 and other items as per the agenda.
Apr 2009
30 Apr · Results
The Management of the Company has opted to submit audited financial results for the entire financial year within three months of end of the financial year
Jan 2009
20 Jan · Board meeting
Inter-alia to consider and take on record and approve the un-audited financial results for the quarter ended December 31, 2008 and other items as per the agenda.
Dec 2008
23 Dec · Business
Board of Directors of Vivimed Labs Limited has discussed and gave its approval for the Agreement and Plan of merger being entered into with Har-met International Inc, USA and there by for the acquisition of Har-met International Inc, USA subject to consents/ permissions/ sanctions as may be required from concerned authorities, Stock Exchanges and/ or members of the Company.23 Dec · Management
Dr. Raj Barathur who has been rendering his services as a Director on the Board of Vivimed Labs Limited has resigned to his directorship with effect from November 27, 2008.
Oct 2008
20 Oct · Board meeting
Inter-alia to consider and take on record and approve the un-audited financial results for the quarter ended September 30, 2008 and other items as per the agenda.3 Oct · Meeting
Outcome of the Annual General Meeting of the Company held on September 27, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
5 Sep · Dividend
Dividend if declared by its members in the Annual General Meeting of the Company to be held on September 27, 2008 , shall be payable on or after the October 02, 2008.
Aug 2008
13 Aug · Management
Mr. Chanakya Chandra Reddy P has been appointed as the Secretary cum Compliance Officer of the Company with effect from July 07,2008.5 Aug · Meeting
Annual General Meeting of the Company will held on September 27, 2008 and close the books from September 24, 2008 to September 27, 2008 for the purpose of Annual General Meeting and payment of dividend.
Jul 2008
22 Jul · Board meeting
Inter-alia to consider and take on record and approve the un-audited financial results for the quarter ended June 30, 2008 and other items as per the agenda.
Jun 2008
30 Jun · Dividend
Meeting of the Board of Directors of the Company has been held on June 28, 2008, whereat the Board has decided among other things, to: 1) The Board recommended payment of 10% dividend (Re.1/- per Fully Paid Equity Share of the company). 2) Board approved withdrawal of offer of 1880000 Convertible Warrants on preferential basis to promoters and persons other than promoters. This issue was approved by Annual General Body in the meeting held on December 26, 2007.20 Jun · Board meeting
To consider, inter alia, the following items: (1) Approval of Audited Financial Statements for the year ended March 31, 2008. (2) Propose cancellation of Preferential issue of shares/warrants to promoters, Promoter groups and others. (3) Any other business with approval of the chair.
May 2008
30 May · Updates
Vivimed Labs Limited had informed the Exchange regarding acquisition of M/s. James Robinson Limited, UK. The Company has now informed the Exchange that: :"All transactions for acquisition are completed on 29/05/2008 and Vivimed Labs Limited through its 100% subsidiary M/s. Vivimed Holdings Limited, took over management and control of the company".21 May · Results
The Management of the Company decided to declare the Audited Financial Results for the full year 2007-08 hence the results will be declared 3 months from the end of the financial year.
Mar 2008
14 Mar · Board meeting
A Meeting of the Board of Directors of the Company has been held at 4.00 P.M. on Wednesday, the 13th March 2008 at the Corporate Office of the Company, whereat the Board has resolved unanimously among other things, to: 1) Investment in shares and/or loan to Vivimed Holdings Limited, a 100% subsidiary of our Company. 2) Provide Corporate Guarantee to the lender of Vivimed Holdings Limited. The above decisions are consequent to Vivimed Labs Limited acquiring James Robinson Limited, a UK based company through its 100% subsidiary company and obtaining financial assistance from banks for this acquisition6 Mar · Board meeting
To consider, inter alia, the following items of business: 1) To consider the proposal of investment in Vivimed Holdings Limited, a 100% Subsidiary of the Company. 2) To consider the proposal of providing Corporate Guarantee to the lender to Vivimed Holdings Limited.
Feb 2008
11 Feb · Business
Board of directors of the Company at it's Board meeting held on 09th February, 2008 had taken following decisions inter alia among others:- Considered the proposal for acquisition of shares of James Robinson Limited and other associated assets (together "James Robinson") from Yule Catto & Co plc subjected to consents/permissions/sanctions as may be required from concerned authorities, Stock Exchanges and/or members of the Company.
Jan 2008
24 Jan · Management
Meeting of the BoDs of the Company has been held on January 23, 2008 whereat the Board has decided among other things : (1) Appointment of Dr. V. Manohar Rao, who was Chairman & Managing Director of VVS Pharmaceuticals & Chemicals Pvt Ltd which has been merged into the Company with effect from 01.04.2006 and who is also a Founder/ Promoter Director of both the Companies, is appointed as Executive Chairman of the Company with immediate effect on such terms and conditions to be decided by the Board of Directors, as desired by all the Directors of the Company, to avail the benefit of his long and valuable experience in establishing and running industrial units. Dr. V Manohar Rao is father of Mr. Santosh Varalwar. (2) Appointment of Additional Directors to the Board.16 Jan · Board meeting
To consider, inter alia, the following terms. (1) To consider and take on record and approve the Un-Audited financial results for the quarter ending December 31, 2007. (2) Appointment of new Directors. (3) Appointment of Chairman in place of Sri.Santosh Varalwar.
Dec 2007
28 Dec · Meeting
Outcome of the 19th Annual General Meeting of the members of the company held on December 27, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Dec · Proceedings of Board Meeting
Meeting of the Board of Directors of the Company has been held on December 26, 2007, where at the Board has decided among other things, to allot shares to the shareholders of M/s. V.V.S. Pharmaceuticals & Chemicals Private Limited pursuant to the scheme sanctioned by the Hon'ble High Court of Karnataka.20 Dec · Board meeting
To consider, inter alia, the following items: 1) Allotment of Shares pursuant to the Merger of VVS Pharmaceuticals Private Limited with VIVIMED Labs Limited; 2) To take note of the Karnataka High Court Order on Amalgamation with VVS Pharmaceuticals Private Ltd. and consider and take on record the Consolidated Audited Financial Results for the year ending 31-03-2007; 3) Appointment of Directors on the Board; 4) Any other business with approval of the chair".6 Dec · News Verification
News Verification : The media had reports that Vivimed Labs Limited may acquire a firm in Europe. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Vivimed Labs Limited has vide its letter inter-alia stated, "The Company has nothing to comment on the news itema and will make the disclosures to the Exchange as and when things materialise."4 Dec · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from December 25, 2007 to December 27, 2007 (both days inclusive), for the purpose of the Annual General Meeting of the Company to be held on December 27, 2007.4 Dec · Proceedings of Board Meeting
Meeting of the Board of Directors of the Company has been held on December 03, 2007, whereat the Board has decided among other things, to: 1) Issue, offer and allot 1880000 Warrants, convertible into equity shares at a later date, to the Promoters and Persons other than the promoters, by way of preferential basis, at an issue price of Rs.148/- per warrant as determined in accordance with the Preferential Issue Guidelines given in Chapter 13 of SEBI (DIP) Guidelines, 2000. 2) Authentication of Final Accounts for the year ended on March 31, 2007. 3) Approval of draft Directors' Report for the year 2006-07. 4) Appointment / Re-appointment of Directors and Statutory Auditor of the Company. 5) Appointment of Company Secretary in place of retiring Company Secretary. 6) Increase of remuneration payable to Managerial Personnel. 7) Fixing the date, time and venue of the ensuing AGM and approval of draft Notice. 8) Allotment of shares pursuant to merger of VVS Pharmaceuticals & Chemicals Pvt Ltd could not be considered due to non receipt of certified copy of the order of approval of merger by Hon'ble High Court of Karnataka. 9) Fixing the Book Closure.
Nov 2007
26 Nov · Board meeting
Inter alia the following items : 1) Adoption of Accounts for the year ended March 31, 2007. 2) The Proposal of issue of Shares/ warrants by way of preferential basis. 3) The Proposal for the Enhancement of Borrowing limits to the Board. 4) Increase of Managerial remuneration. 5) The Fixation if Book Closure. 6) The allotment of Shares pursuant to the Merger. 7) Any other item with permission of the Chair.16 Nov · Issue of Warrants
Our Company decided to withdraw the proposal for issue of warrants on preferential basis to the promoters and others vide resolution passed in the EGM Dtd.30.12.2006. Therefore, we request you to treat the proposal for issue of warrants on preferential basis to promoters and others is hereby withdrawn
Oct 2007
23 Oct · Board meeting
Inter alia to consider and take on record and approve the Un-audited Financial Results for the quarter ended on September 30, 2007 and other business as per the agenda.
Sep 2007
13 Sep · News Verification
News Verification : The media had reports that Vivimed Labs Limited has signed a product supply deal with three major MNC's for around Rs. 40 crore per annum. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Vivimed Labs Limited has vide its letter inter-alia stated, "The report submitted by the media was from their available sources. We do not wish to comment on price sensitive information. As and when things materialize, we will make all such disclosures to the Exchange."
Jul 2007
23 Jul · Board meeting
Inter alia to consider and take on record and approve the Un-audited Financial Results for the quarter ending on June 30, 2007 and other business as per the agenda.
May 2007
3 May · Issue of Foreign Currency Convertible Bonds
April 30, 2007 that "Vivimed Labs Limited obtained consent of its shareholders to issue FCCBs up to US$ 75 Million in December 2006. Hanover Square capital (UK) Ltd was appointed as Leas Manager, Atherstone Capital Asia Limited as Financial Advisor and Rajani Associates as legal advisers as to Indian Law, of the FCCB Issue. FCCBs for US$ 12 million 1% Coupon Foreign Currency Convertible Bonds("FCCBs") with a maturity of 5 years and 1 day have been subscribed. After completion of all formalities, the FCCBs will be listed on the Singapore Stock Exchange. The FCCBs are convertible into ordinary shares of the Company at a maximum conversion price of Rs. 185 per share. The conversion price of the FCCBs may be revised in certain circumstances. The FCCBs have a 8% per annum yield to maturity. The said issue was made at 10% premium to the reference date price. Under Greenshoe option subscription for further US$ 3 million is expected shortly."
Apr 2007
23 Apr · Board meeting
Meeting on 30 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”
Mar 2007
6 Mar · Miscellaneous
'Vivimed Labs approved as a Global Supplier to L'Oreal - France'. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2007
24 Jan · Board meeting
Meeting on 30 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”4 Jan · Meeting
The members at the Extra Ordinary General Meeting of the company held on 30th December, 2006 at 11.30 A.M. at the Registered Office of the Company at 78/A, Kolhar Industrial Area, Bidar-585403, Karnataka, inter alia have accorded/approved the following: 1) Allotment of upto 14,10,000 convertible share warrants to the person other than promoters at a price of Rs 169.00/- per warrants with face value of Rs 10/- each. 2) Allotment of upto 4,70,000 convertible share warrants to the promoters of the company at a price of Rs 169.00/- per warrants with the face value of Rs 10/- each. 3) Board is authorized to borrow in aggregate of Rs.200 Crores over and above the aggregate of paid-up capital and free reserves of the Company. 4) Board is authorized to ton issue up to US $ 75 million by way of Foreign Currency Convertible Bond (FCCB)/ADRs/GDRs in one or trances